Loading...

Robust Clinical Uptake Will Expand Advanced Cancer Therapy Adoption

Published
17 Aug 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-58.7%
7D
11.4%

Author's Valuation

US$9.6285.8% undervalued intrinsic discount

AnalystConsensusTarget Fair Value